Benzinga - by Avi Kapoor, Benzinga Staff Writer.
U.S. stock futures were higher this morning, with the Nasdaq futures gaining over 100 points on Friday.
Shares of iRobot Corporation (NASDAQ: IRBT) shares fell sharply in today’s pre-market trading.
The European Union's competition watchdog is poised to reject Amazon.com Inc's (NASDAQ: AMZN) ambitious $1.7-billion acquisition of iRobot, The Wall Street Journal reported, citing sources close to the matter.
iRobot shares dipped 35.8% to $15.16 in pre-market trading.
Here are some big stocks recording losses in today’s pre-market trading session.
- AST SpaceMobile, Inc. (NASDAQ: ASTS) shares tumbled 18.5% to $3.39 in pre-market trading. AST SpaceMobile announced a $100 million offering of common stock. The company also announced a strategic investment from AT&T Inc (NYSE: T), Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) and Vodafone.
- MorphoSys AG (NASDAQ: MOR) shares declined 10.7% to $9.14 after falling 6% on Wednesday. Morgan Stanley analyst James Quigley, on Tuesday, downgraded MorphoSys from Overweight to Equal-Weight.
- Absci Corporation (NASDAQ: ABSI) shares fell 5.8% to $3.41 in pre-market trading. Absci recently appointed seasoned R&D executive Professor Sir Menelas “Mene” Pangalos to its Board of Directors and as co-chair of Absci’s Scientific Advisory Board.
- Diversified Energy Company PLC (NYSE: DEC) shares declined 4.2% to $12.00 in pre-market trading.
- XPeng Inc. (NYSE: XPEV) shares fell 3.9% to $9.49 in pre-market trading after declining over 2% on Thursday.
- Chegg, Inc. (NYSE: CHGG) shares fell 3.7% to $9.69 in pre-market trading. Goldman Sachs analyst Eric Sheridan downgraded Chegg from Neutral to Sell and lowered the price target from $10 to $8.
- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) shares fell 3.1% to $3.17 in pre-market trading. Arcutis Canada recently announced Health Canada acceptance of the supplement to a new drug submission for Roflumilast Foam 0.3% for seborrheic dermatitis in individuals 9 years of age and older.
Now Read This: Investor Sentiment Increases Following Economic Reports; Dow Jumps Over 200 Points
Don’t forget to check out our premarket coverage here
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.